Year-end review: review and prospect of the new reform
The New Deal, which began in early 2015, has had the worst impact on the industry in history, although it was not drafted and published by the department of drug control. Followed by the industry as "
Attack or defense? The pharmaceutical market is going to change
In 2018, China's pharmaceutical industry will usher in a decisive year of consistency evaluation. Whether it's the aggressive offense or the defensive choice of the rafer in the big wave, it's a sign
"Fire safety, we are in action" -- yongda 2017 annual fire drill
In order to strengthen the fire safety skills of the staff and enable all employees to master the use of various fire equipment within the company and the ability to organize escape and emergency resp
What are the warnings for medical professionals about the decline in red, yellow and blue shares and the loss of $300 million in
Red, yellow, blue, although industry domain, but under the crisis of the market, has enough to make all pharmaceutical enterprise of warning: if the illegal cost low status is still not enough to make